We are live on ! Find out more
XENT

Intersect ENT, Inc

Delisted

XENT was delisted on the 12th of May, 2022.

131 hedge funds and large institutions have $826M invested in Intersect ENT, Inc in 2022 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 48 increasing their positions, 40 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

92% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 12

20% more repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 40

8% more funds holding

Funds holding: 121131 (+10)

1% less capital invested

Capital invested by funds: $831M → $826M (-$5.14M)

33% less funds holding in top 10

Funds holding in top 10: 32 (-1)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $644K

Holders
131
Holders Change
+10
Holders Change %
+8.26%
% of All Funds
2.07%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
23
Increased
48
Reduced
40
Closed
12
Calls
Puts
$644K
Net Calls
-$644K
Net Calls Change
+$136K
Name Holding Trade Value Shares
Change
Change in
Stake
E
26
Ergoteles
New York
$9.34M +$553K +20,193 +6%
GF
27
Gabelli Funds
New York
$8.62M +$2.06M +75,202 +32%
JP Morgan Chase
28
JP Morgan Chase
New York
$8.2M +$120K +4,382 +2%
CCM
29
Crabel Capital Management
California
$7.66M
N
30
Natixis
France
$6.85M -$3.33M -121,600 -33%
Norges Bank
31
Norges Bank
Norway
$6.81M
Charles Schwab
32
Charles Schwab
California
$6.79M +$108K +3,942 +2%
Qube Research & Technologies (QRT)
33
Qube Research & Technologies (QRT)
United Kingdom
$6.48M +$3.04M +110,863 +92%
Calamos Advisors
34
Calamos Advisors
Illinois
$6.16M +$475K +17,346 +9%
PCM
35
Prelude Capital Management
New York
$5.52M +$4.42M +161,258 +451%
State of Wisconsin Investment Board
36
State of Wisconsin Investment Board
Wisconsin
$5.47M -$1.27M -46,500 -19%
YCM
37
Yakira Capital Management
Connecticut
$4.88M +$2.93M +106,967 +159%
LP
38
LMR Partners
United Kingdom
$4.86M +$2.57M +93,679 +117%
CC
39
Carlson Capital
Texas
$4.34M +$4.25M +155,000 New
GCIA
40
Gabelli & Co Investment Advisers
New York
$4.29M +$912K +33,286 +28%
HSBC Holdings
41
HSBC Holdings
United Kingdom
$4.19M +$4.1M +149,449 New
CCM
42
Chicago Capital Management
Illinois
$3.95M +$3.87M +141,111 New
Citadel Advisors
43
Citadel Advisors
Florida
$3.94M +$3.13M +114,347 +438%
OR
44
Olympiad Research
Connecticut
$3.53M +$960K +35,048 +39%
Marshall Wace
45
Marshall Wace
United Kingdom
$3.39M +$1.52M +55,474 +85%
Capstone Investment Advisors
46
Capstone Investment Advisors
New York
$3.38M +$700K +25,526 +27%
HA
47
Havens Advisors
New York
$3.06M -$1.43M -52,103 -32%
Bank of New York Mellon
48
Bank of New York Mellon
New York
$3.04M -$8.88K -324 -0.3%
Deutsche Bank
49
Deutsche Bank
Germany
$2.99M -$50.6K -1,845 -2%
GLAM
50
Gardner Lewis Asset Management
Pennsylvania
$2.88M +$2.82M +102,827 New

XENT Hedge Fund Activity: Q1 2022 in Review

131 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Intersect ENT, Inc (XENT) for Q1 2022, worth a combined $826M — down 0.62% from $831M a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new XENT positions and 12 closed out — a net gain of 11 holders — while 48 added to existing stakes and 40 trimmed.

The largest buyer was Healthcare of Ontario Pension Plan (HOOPP) Trust Fund, adding an estimated $9.95M. The largest seller was Kite Lake Capital Management (UK), exiting entirely with an estimated $36M sold.

  • 131 institutional investors held Intersect ENT, Inc (XENT) as of Q1 2022, up from 121 in Q4 2021.
  • Funds reported $826M of Intersect ENT, Inc stock for Q1 2022, down 0.62% quarter-over-quarter.
  • 23 funds opened new Intersect ENT, Inc positions in Q1 2022 and 12 closed out, a net change of +11 holders.
  • The largest Intersect ENT, Inc buyer in Q1 2022 was Healthcare of Ontario Pension Plan (HOOPP) Trust Fund, an estimated $9.95M added.
  • The largest Intersect ENT, Inc seller in Q1 2022 was Kite Lake Capital Management (UK), an estimated $36M sold.

Based on aggregated 13F filings for Q1 2022.